BullFrog AI Secures Exclusive Licensing Agreement with Johns Hopkins’ APL for AI Technology

BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need. Visit BFRGinfo.com to learn more.

Видео BullFrog AI Secures Exclusive Licensing Agreement with Johns Hopkins’ APL for AI Technology канала RedChip Companies